Skip to Content

Ardeparin Pregnancy and Breastfeeding Warnings

Ardeparin is also known as: Normiflo

Ardeparin Pregnancy Warnings

Animal studies using subcutaneous doses 3 times (rats) to 10 times (rabbits) the recommended human dosage did not result in impaired fertility or fetal harm. However, doses of ardeparin 7 times (rats) to 11 times (rabbits) the recommended human dosage resulted in scoliosis, interventricular septal defects, stenosis of the aortic arch and pulmonary trunk, and fused sternebrae.

Ardeparin has been assigned to pregnancy category C by the FDA. Animals studies using subcutaneous dosing did not result in impaired fertility or fetal harm. However, intravenously administered doses in pregnant animals revealed evidence of teratogenic effects. There are no controlled data in human pregnancy. Ardeparin should only be used during pregnancy when the benefit outweighs the risk.

See references

Ardeparin Breastfeeding Warnings

There are no data on the excretion of ardeparin into human milk. The manufacturer recommends that caution be used when administering ardeparin to nursing women.

See references

References for pregnancy information

  1. "Product Information. Normiflo (ardeparin)." Wyeth-Ayerst Laboratories, Philadelphia, PA.

References for breastfeeding information

  1. "Product Information. Normiflo (ardeparin)." Wyeth-Ayerst Laboratories, Philadelphia, PA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.